Literature DB >> 1697394

Intravenous immunoglobulin for polymyositis and dermatomyositis.

P Cherin, S Herson, B Wechsler, J C Piette, O Bletry, J M Ziza, C Degennes, P Godeau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1697394     DOI： 10.1016/0140-6736(90)91630-s

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  The idiopathic inflammatory myopathies and their treatment.

Authors:  J Walton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

Review 2.  Recent advances on pathogenesis and therapies in systemic sclerosis.

Authors:  Norihito Yazawa; Manabu Fujimoto; Kunihiko Tamaki
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

3.  Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.

Authors:  Sevim Barbasso Helmers; Maryam Dastmalchi; Helene Alexanderson; Inger Nennesmo; Mona Esbjörnsson; Björn Lindvall; Ingrid E Lundberg
Journal:  Ann Rheum Dis       Date:  2007-02-02       Impact factor: 19.103

Review 4.  Intravenous immunoglobulin in neurological disease: a specialist review.

Authors:  C M Wiles; P Brown; H Chapel; R Guerrini; R A C Hughes; T D Martin; P McCrone; J Newsom-Davis; J Palace; J H Rees; M R Rose; N Scolding; A D B Webster
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

Review 5.  [Paraneoplastic autoimmune dermatoses].

Authors:  D Didona; M Hertl
Journal:  Hautarzt       Date:  2021-03-01       Impact factor: 0.751

Review 6.  Recognition and management of myositis.

Authors:  P Cherin
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

7.  Indications for intravenous gammaglobulin therapy in inflammatory myopathies.

Authors:  P Cherin; S Herson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

8.  Aldolase predicts subsequent myopathy occurrence in systemic sclerosis.

Authors:  Cécile Tolédano; Murielle Gain; Adrien Kettaneh; Bruno Baudin; Catherine Johanet; Patrick Chérin; Sébastien Rivière; Jean Cabane; Kiet Phong Tiev
Journal:  Arthritis Res Ther       Date:  2012-06-22       Impact factor: 5.156

9.  Multifactorial study of inflammatory myopathies. Report of 29 cases.

Authors:  C Angelini; E Menegazzo; M Fanin
Journal:  Ital J Neurol Sci       Date:  1993-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.